| Charles Thomas Smith Ii, RPH | |
|
23355 5th Ave, Florala, AL 36442-3818 | |
| (334) 858-3291 | |
| (334) 858-5254 |
| Full Name | Charles Thomas Smith Ii |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 23355 5th Ave, Florala, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114243045 | NPI | - | NPPES |
| 100001169 | Medicaid | AL | |
| 100513800 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 9068 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Charles Thomas Smith Ii, RPH 23355 5th Ave, Florala, AL 36442-3818 Ph: (334) 858-3291 | Charles Thomas Smith Ii, RPH 23355 5th Ave, Florala, AL 36442-3818 Ph: (334) 858-3291 |
News Archive
In the Huffington Post's "Impact" blog, Carolyn Miles, president and CEO of Save the Children, writes about the Frontline Health Workers Coalition's call on the U.S. government to train 250,000 new frontline health workers in developing countries, stating, "At a time when every dollar counts more than ever, the new Frontline Health Workers Coalition believes this focus is the most cost-effective way to save mothers' and children's lives around the world, address global health threats, and help advance strategic U.S. interests in a secure and prosperous world."
Eight years ago, researchers at the University of North Carolina at Chapel Hill launched a new kind of clinical trial to compare the effectiveness of online therapy - delivered through group chat sessions - to face-to-face group therapy for the treatment of bulimia nervosa, an eating disorder marked by recurrent episodes of binge eating (or eating an unusually large amount of food and feeling out of control) coupled with purging behaviors such as vomiting, laxative abuse, or excessive exercise.
Neuronal degeneration is the most severe long-term consequence of repetitive seizures in patients with epilepsy, which until now was thought to be primarily caused by excitotoxicity, or over-stimulation of the neurons.
Appian Labs, LLC, a biopharmaceutical company specializing in advanced therapeutic design and delivery, has announced an exclusive Development and Commercial License Agreement for the company's AppiForm™ Modular Release System with Capsugel, the world's leading provider of dosage form solutions to the pharmaceutical and related healthcare industries. The agreement provides for Capsugel to utilize the AppiForm Modular Release System for customizable drug delivery profiles.
A new method of using adult stem cells as a model for the hereditary condition Gaucher disease could help accelerate the discovery of new, more effective therapies for this and other conditions such as Parkinson's, according to new research from the University of Maryland School of Medicine.
› Verified 3 days ago
Dr. William Taylor Benton Iii, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23355 5th Ave, Florala, AL 36442 Phone: 334-858-3291 Fax: 334-858-5254 | |
Samantha E Caton, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23355 5th Ave, Florala, AL 36442 Phone: 334-858-3292 Fax: 334-858-5254 | |
Dr. Magen Adams, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23355 5th Ave, Florala, AL 36442 Phone: 334-858-3291 | |
Miss Jessica Renee Fowler, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23355 5th Ave, Florala, AL 36442 Phone: 334-858-3291 Fax: 334-858-5254 | |
Mr. Thomas Kevin Frye, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23355 5th Ave, Florala, AL 36442 Phone: 334-858-3291 Fax: 334-858-5254 |